Caring Deeply About People Pays; Ask Jeff Aronin

Posted on May 15, 2018

Despite all the advances in Science and technology, some diseases have little or no treatment options. Fortunately, people like Paragon Biosciences’ Chief Executive Officer Jeff Aronin are always striving to find solutions.

An investor and incubator, Paragon Biosciences owns several companies that develop innovative products. The company focuses on immune system diseases, central nervous system disorders, and rare genetic dermatological conditions.

 

Currently, 6,000 diseases have no Cure.

Paragon Biosciences strives to find the cure for some of these diseases. The company identifies situations where patients need treatment, but they cannot get it. The business then establishes dynamic companies that research those conditions.

Paragon provides these companies with all the support and infrastructure they need to succeed. The result is innovative medicines that alleviate the suffering of those in need.

 

Paragon competes with the big boys.

Paragon is a highly successful pharmaceutical business. The company now competes with the industry’s big boys. Its business portfolio includes companies such as Precision BP, Castle Creek Pharmaceuticals, and Harmony Biosciences.

Each of these businesses handles a specific part of the company’s primary purpose of developing innovative treatment options. In the last ten years, Paragon has received 13 approvals from the Food and Drug Administration.

 

Great leadership delivers success.

Aronin possesses skills in brand marketing, finance, strategy and business development (Weizmann-usa). Additionally, he has enough experience in handling sensitive corporate transactions such as mergers and acquisitions. He is the leader the company of the 21st century needs.

 

Jeff Aronin is a contrarian strategist.

Typically, large biotechnology and pharmaceutical companies do not invest in diseases affecting less than 200,000 people. It does not make economic sense. Jeff Aronin thinks and does things differently. He sees these overlooked areas as excellent opportunities for helping humanity.

Paragon Biosciences does things differently, too. The CEO’s innovative approach to leadership and business management sets the company apart from the competition.